Arvinas, Inc. (ARVN)
10.18
-0.08
(-0.78%)
USD |
NASDAQ |
May 07, 16:00
10.18
0.00 (0.00%)
After-Hours: 16:59
Arvinas SG&A Expense (TTM) : 95.90M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 10.76B |
| EyePoint, Inc. | 37.79M |
| Apellis Pharmaceuticals, Inc. | 550.26M |
| Elanco Animal Health, Inc. | 1.089B |
| Gossamer Bio, Inc. | 37.63M |